TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 19.39M | 14.31M | 12.34M | 6.93M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 19.39M | 14.31M | 12.34M | 6.93M | |
| Cost of Revenue | 8.69M | 4.05M | 6.42M | 3.44M | |
| Gross Profit | 10.71M | 10.27M | 5.92M | 3.49M | |
| SG&A Expenses | 13.35M | 13.08M | 6.54M | 3.27M | |
| Depreciation & Amortization | 252.00K | 397.00K | 156.00K | 136.00K | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 22.28M | 17.11M | 13.29M | 6.85M | |
| Operating Income | -2.89M | -2.80M | -948.00K | 82.00K | |
| Income Before Tax | -4.68M | -3.08M | -1.06M | -38.00K | |
| Income Tax Expenses | -- | 18.00K | -- | -- | |
| Earnings from Continuing Operations | -4.68M | -3.10M | -1.06M | -38.00K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -4.68M | -3.10M | -1.06M | -38.00K | |
| EBIT | -2.89M | -2.80M | -948.00K | 82.00K | |
| EBITDA | -2.85M | -2.77M | -925.70K | 218.00K | |
| EPS Basic | -0.42 | -0.29 | -0.10 | 0.00 | |
| Normalized Basic EPS | -0.13 | -0.18 | -0.06 | 0.00 | |
| EPS Diluted | -0.42 | -0.29 | -0.10 | 0.00 | |
| Normalized Diluted EPS | -0.13 | -0.18 | -0.06 | 0.00 | |
| Average Basic Shares Outstanding | 11.27M | 10.69M | 10.69M | 10.69M | |
| Average Diluted Shares Outstanding | 11.27M | 10.69M | 10.69M | 10.69M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |